266 related articles for article (PubMed ID: 26109723)
21. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity.
Bajaj BG; Verma SC; Lan K; Cotter MA; Woodman ZL; Robertson ES
Virology; 2006 Jul; 351(1):18-28. PubMed ID: 16647097
[TBL] [Abstract][Full Text] [Related]
22. Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signaling-dependent transcription.
Kusano S; Eizuru Y
Biochem Biophys Res Commun; 2010 Jun; 396(3):608-13. PubMed ID: 20417616
[TBL] [Abstract][Full Text] [Related]
23. Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers.
Fujimuro M; Hayward SD
J Mol Med (Berl); 2004 Apr; 82(4):223-31. PubMed ID: 14991150
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
25. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation.
Cai Q; Xiao B; Si H; Cervini A; Gao J; Lu J; Upadhyay SK; Verma SC; Robertson ES
PLoS Pathog; 2012; 8(3):e1002566. PubMed ID: 22396649
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
[TBL] [Abstract][Full Text] [Related]
29. Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.
Petre CE; Sin SH; Dittmer DP
J Virol; 2007 Feb; 81(4):1912-22. PubMed ID: 17121789
[TBL] [Abstract][Full Text] [Related]
30. Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.
Chen W; Hilton IB; Staudt MR; Burd CE; Dittmer DP
J Virol; 2010 Apr; 84(8):3898-908. PubMed ID: 20130056
[TBL] [Abstract][Full Text] [Related]
31. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.
Sarek G; Ma L; Enbäck J; Järviluoma A; Moreau P; Haas J; Gessain A; Koskinen PJ; Laakkonen P; Ojala PM
Oncogene; 2013 Feb; 32(9):1091-8. PubMed ID: 22469985
[TBL] [Abstract][Full Text] [Related]
33. Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
Lu M; Breyssens H; Salter V; Zhong S; Hu Y; Baer C; Ratnayaka I; Sullivan A; Brown NR; Endicott J; Knapp S; Kessler BM; Middleton MR; Siebold C; Jones EY; Sviderskaya EV; Cebon J; John T; Caballero OL; Goding CR; Lu X
Cancer Cell; 2013 May; 23(5):618-33. PubMed ID: 23623661
[TBL] [Abstract][Full Text] [Related]
34. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
Skalsky RL; Hu J; Renne R
J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
[TBL] [Abstract][Full Text] [Related]
35. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
[TBL] [Abstract][Full Text] [Related]
36. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta.
Hagen T
J Virol; 2009 Jun; 83(12):6312-7. PubMed ID: 19321622
[TBL] [Abstract][Full Text] [Related]
38. CDK9 inhibitors reactivate p53 by downregulating iASPP.
Wu J; Liang Y; Tan Y; Tang Y; Song H; Wang Z; Li Y; Lu M
Cell Signal; 2020 Mar; 67():109508. PubMed ID: 31866490
[TBL] [Abstract][Full Text] [Related]
39. Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Kaul R; Verma SC; Robertson ES
Virology; 2007 Aug; 364(2):317-29. PubMed ID: 17434559
[TBL] [Abstract][Full Text] [Related]
40. A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
Qiu S; Cai Y; Gao X; Gu SZ; Liu ZJ
Cancer Lett; 2015 Jan; 356(2 Pt B):910-7. PubMed ID: 25444901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
